This study revealed that PMFs ameliorated the core symptoms of AD-like mice, including memory decline, anxiety-like states, neural cell damage in hippocampal region, and increased levels of Aβ and p-Tau in the brain. This evidence concerns the gene MAPT and Alzheimer disease.